Our Top Ten in 1999
Our list of the top 10 issues and events from 1999--from the Internet (scaring purchasing groups and reinvigorating the biotech industry); to Pfizer's war on Warner-Lambert; to indigestion among device dealmakers; and to the rebirth of research-based in vitro diagnostics.
You may also be interested in...
Gilead is closely evaluating the situation for remdesivir in India as the country tackles shortages of the drug, which has several local licensees, with instances of black marketing adding to the local woes. The US firm clearly will not want any momentum towards possible compulsory licensing as initiated by Hungary and Russia, even as Indian firms have cut prices of the antiviral.
Amid a case of re-infection of a vaccinated healthcare worker in western China’s Xi’an city, and ongoing debate over domestic vaccines' efficacy, increasing attention is being paid in China to raising inoculation rates for COVID-19 and moving towards herd immunity.
The company announced new research investments and partnerships with the American Diabetes Association and the T1D Exchange to address racial disparities in treatment of diabetes.